Library Pharma, Inc.
Records under this name other than patents Library Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Library Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,242,491 | Use of creatine or creatine compounds for skin preservation Term ended Term ended Jun 25, 2019 · From the USPTO record | Term ended | Term ended Jun 25, 2019 | From the USPTO record |
| US 7,186,754 | Use of creatine or creatine compounds for skin preservation Lapsed on the fee record Ended Mar 6, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 6, 2019 | From the USPTO record |
| US 6,075,031 | Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders Term ended Term ended Aug 19, 2017 · From the USPTO record | Term ended | Term ended Aug 19, 2017 | From the USPTO record |
| US 6,166,249 | Creatine pyruvates Term ended Term ended Jul 11, 2017 · From the USPTO record | Term ended | Term ended Jul 11, 2017 | From the USPTO record |
| US 7,285,573 | Use of Creatine or Creatine Analogs for the Treatment of Diseases of the Nervous System Term ended Term ended Mar 11, 2015 · Medium confidence | Term ended | Term ended Mar 11, 2015 | Medium confidence |
| US 6,706,764 | Use of creatine or creatine analogs for the treatment of diseases of the nervous system Term ended Term ended Nov 8, 2014 · From the USPTO record | Term ended | Term ended Nov 8, 2014 | From the USPTO record |